ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687527 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687527; 2) Community: the network communities that were significantly associated with the response to NSC 687527; 3) Molecule: the relationships between components within communities and NSC 687527; 4) MDR: the compounds that were significantly associated with the NSC 687527.

NSC Compound Enrichment Correlation
NSC 710326 Null 0.0434721470609156 0.17052866
NSC 711077 Null 0.0434721470609156 0.57739965
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.45705067
NSC 720134 Null 0.0434721470609156 -0.068022444
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.37186975
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0434721470609156 -0.018113696
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0434721470609156 0.15072738
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0434721470609156 0.33087172
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0434721470609156 0.65686495
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0434721470609156 0.099129456
Total:80  Current:62    [First] [Prev] [Next] [Last]